Diabetes & Metabolic Syndrome Clinical Research & Reviews
译名:糖尿病与代谢综合征-临床研究与评论
Diabetes & Metabolic Syndrome-Clinical Research & Reviews
3-5
2026
影响因子区间
211天
平台估算
25%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia and the National Diabetes, Obesity and Cholesterol Foundation (NDOC). **This journal will receive its first journal Impact Factor in 2023** Diabetes and Metabolic Syndrome: Clinical Research and Reviews aims to reach out to healthcare professionals, diabetes educators and other stakeholders, providing them with a global platform to submit their research on diabetes care. The journal publishes research covering various aspects of diabetes and related diseases like cardiovascular diseases, diabetic neuropathy, weakening eyesight, sexual dysfunction, management of diabetes mellitus, obesity, insulin management and metabolic syndrome, among others. The journal publishes peer-reviewed original articles, reviews, short communication, case reports, letter to the Editor and expert comments. Reviews and mini-reviews are especially welcomed for those areas within endocrinology undergoing rapid changes.
【译文】《糖尿病和代谢综合征:临床研究和评论》是 DiabetesIndia 和国家糖尿病、肥胖和胆固醇基金会 (NDOC) 的官方期刊。 **该期刊将于 2023 年获得第一个期刊影响因子** 糖尿病和代谢综合征:临床研究和评论旨在接触医疗保健专业人员、糖尿病教育者和其他利益相关者,为他们提供一个全球平台来提交糖尿病护理研究。该杂志发表的研究涵盖糖尿病及相关疾病的各个方面,如心血管疾病、糖尿病神经病变、视力下降、性功能障碍、糖尿病管理、肥胖、胰岛素管理和代谢综合征等。该杂志发表同行评审的原创文章、评论、简短的交流、案例报告、致编辑的信和专家评论。对于那些正在经历快速变化的内分泌学领域,评论和小型评论尤其受欢迎。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |